Neogen Thyrocryn (levothyroxine sodium tablets) (2 products)
Recall announced September 9, 2022 by Neogen Corporation, posted by the U.S. Food and Drug Administration (FDA). Reason: Product is subpotent. It affects dogs. The agency has closed this recall.
- Brands
- Neogen
- Where sold
- Nationwide USA and Guam
- Last updated
- November 19, 2026
Products included
- Thyrocryn (levothyroxine sodium tablets), USP, 0.1 mg, Net Contents: [180 or 1000] tablets per bottle, For oral use in dogs only, Manufactured for: Aspen Veterinary Resources, LTD, Liberty, MO 64068. NDC 180 count bottle: 46066-090-38 (Count, Lot, Expiry: [180 count bottles] Lot BM0120221T, exp 6/20/2023; Lot BM0526211T, exp 11/26/2022; Lot BM0808221T, exp 8/8/2023 [1,000 count bottles] Lot BM0120221Z, exp 6/20/2023; Lot BM0526211Z, exp 11/26/2022; Lot BM0808221Z, exp 8/8/2023)
- ThyroKare (levothyroxine sodium tablets), USP, 0.1 mg, Net Contents: [180 or 1000] tablets per bottle, For oral use in dogs only, Manufactured by: Neogen Corporation, 944 Nandino Blvd, Lexington, KY 40511. NDC 180 count bottle: 59051-9100-0 (Count, Lot, Expiry: [180 count bottles] Lot BM0526211T, exp 11/26/2022; Lot BM0120221T, exp 6/20/2023; Lot BM0808221T, exp 8/8/2023 [1,000 count bottles] Lot BM0526211Z, exp 11/26/2022; Lot BM0120221Z, exp 6/20/2023; Lot BM0808221Z, exp 8/8/2023)
Read the official notice. Always compare the codes on your package with the official notice. It is the final word.
Has your pet used this product and seems unwell? Call your veterinarian or an emergency animal hospital now.
